Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis

British Journal of Surgery

Volumn 83, Issue 3, 1996, Pages 422-423

  Frick, T ^a   Buchler M M ^b   Gaus, W ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

CHRONIC PANCREATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029882199     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.1800830345     Document Type: Letter

References (3)

1. Biichler MW, Friess H, Klempa I et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992; 163: 125-31.
2. Pederzoli P, Bassi C, Falconi M, Camboni MG and the Italian study group. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 1994; 81: 265-9.
3. Montorsi M, Zago M, Mosca F et al. Efficacy of octreotide in the prevention of pancreatic fistulas after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 1995; 117: 26-31.